The use of Yttrium-90 Ibritumomab Tiuxetan ( 90 Y-IT) as a consolidation therapy in high-risk patients with diffuse large B-cell lymphoma ineligible for autologous stem-cell transplantation

full text is not available in portal

Category:: Magazine publication
Type:: Magazine publication
Published in:: Wspolczesna Onkologia-Contemporary Oncology no. 1, pages 43 - 47,
ISSN: 1428-2526
ISSN:: 1428-2526
Publication year:: 2015
DOI:: Digital Object Identifier (open in new tab) 10.5114/wo.2015.50012
Verified by:: No verification

seen 51 times

Search